Your browser doesn't support javascript.
loading
Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.
Legan, Emily R; Liu, Yi; Arce, Nicholas A; Parker, Ernest T; Lollar, Pete; Zhang, X Frank; Li, Renhao.
Afiliação
  • Legan ER; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA.
  • Liu Y; Department of Bioengineering, Lehigh University, Bethlehem, PA.
  • Arce NA; Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA.
  • Parker ET; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA.
  • Lollar P; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA.
  • Zhang XF; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA.
  • Li R; Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA.
Blood ; 141(10): 1221-1232, 2023 03 09.
Article em En | MEDLINE | ID: mdl-36580664

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Doença de von Willebrand Tipo 2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Gabão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Doença de von Willebrand Tipo 2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Gabão